Baytril 100 Injectable Solution is a drug owned by ELANCO US INC. It is protected by 1 US drug patent filed in 2015. All patents have expired. Details of Baytril 100 Injectable Solution’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US5756506 | Active | |
Exclusivity Information
Baytril 100 Injectable Solution holds 1 exclusivity out of which 1 has expired. Details of Baytril 100 Injectable Solution's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Dec 23, 2017 |
About Baytril 100 Injectable Solution
Baytril 100 Injectable Solution is a drug
owned by ELANCO US INC.
Baytril 100 Injectable Solution uses
Enrofloxacin as the active
ingredient.
Active Ingredient:
Baytril 100 Injectable Solution uses
Enrofloxacin as the active ingredient.
Check out other Drugs and Companies using
Enrofloxacin ingredient.